Your browser doesn't support javascript.
loading
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
Beckers, Rhiannon K; Selinger, Christina I; Vilain, Ricardo; Madore, Jason; Wilmott, James S; Harvey, Kate; Holliday, Anne; Cooper, Caroline L; Robbins, Elizabeth; Gillett, David; Kennedy, Catherine W; Gluch, Laurence; Carmalt, Hugh; Mak, Cindy; Warrier, Sanjay; Gee, Harriet E; Chan, Charles; McLean, Anna; Walker, Emily; McNeil, Catriona M; Beith, Jane M; Swarbrick, Alexander; Scolyer, Richard A; O'Toole, Sandra A.
Afiliação
  • Beckers RK; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Selinger CI; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Vilain R; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Madore J; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Wilmott JS; Melanoma Institute Australia, Sydney, NSW, Australia.
  • Harvey K; Melanoma Institute Australia, Sydney, NSW, Australia.
  • Holliday A; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Cooper CL; Melanoma Institute Australia, Sydney, NSW, Australia.
  • Robbins E; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Gillett D; The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • Kennedy CW; The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • Gluch L; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Carmalt H; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Mak C; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Warrier S; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Gee HE; The Strathfield Breast Centre, Strathfield, NSW, Australia.
  • Chan C; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • McLean A; The Strathfield Breast Centre, Strathfield, NSW, Australia.
  • Walker E; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • McNeil CM; The Strathfield Breast Centre, Strathfield, NSW, Australia.
  • Beith JM; Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Swarbrick A; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Scolyer RA; The Strathfield Breast Centre, Strathfield, NSW, Australia.
  • O'Toole SA; Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Histopathology ; 69(1): 25-34, 2016 Jul.
Article em En | MEDLINE | ID: mdl-26588661

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mama / Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Antígeno B7-H1 / Neoplasias de Mama Triplo Negativas / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mama / Biomarcadores Tumorais / Linfócitos do Interstício Tumoral / Antígeno B7-H1 / Neoplasias de Mama Triplo Negativas / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article